Open access
Open access
Powered by Google Translator Translator

Study shows patients with circulating tumor DNA are at increased risk of relapse after surgery for resectable colorectal cancer

19 Jan, 2023 | 14:18h | UTC

Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer – Nature Medicine – Nature Medicine

Commentary: Data Support ctDNA as a Prognostic Marker for Recurrence/Benefit in Colorectal Cancer – Cancer Network


Commentary on Twitter


Stay Updated in Your Specialty

Telegram Channels

WhatsApp alerts 10-day free trial

No spam, just news.